New occurrence of the new Pestivirus Linda virus in a pig farm in Carinthia, Austria\u00a0<\/title>\r\nLinda virus (LindaV) was first identified in a pig farm in Styria, Austria in 2015 and has been associated with type A-II congenital tremor (CT) in newborn piglets. Since then, only one LindaV-affected farm within 10 km of the initially affected farm has been retrospectively discovered. Here, we report the recent outbreak of a new LindaV strain on a full-cycle farm in the federal state of Carinthia, Austria. No connection could be discovered between this farm and previously affected farms. The outbreak was characterized by severe cases of CT in multiple litters and high pre-weaning mortality. A visit to the farm two months after the onset of clinical symptoms, followed by a diagnostic study, revealed the presence of several viremic piglets at six weeks of age. These animals shed large amounts of virus through feces and saliva, implying an important epidemiological role for virus transmission within and between herds. The new strain LindaV was isolated and genetically characterized. The findings underscore a low prevalence of LindaV in the Austrian swine population and highlight the threat when introduced into a herd of pigs. Furthermore, the results call attention to the need to better understand the persistence and transmission routes of this enigmatic pestivirus in the swine population.<\/p>\r\n
Keywords: emerging disease; flaviviridae; pestivirus; atypical swine pestivirus; Bungowannah virus; congenital tremor; lindavirus; new strain of virus Linda; virus; Austria</\/p>\r\n1. Introduction<\/hd>\r\nthe generoPestivirus<\/emph> within the familyFlaviviridae<\/emph> includes economically important pathogens of pigs. In addition to OIE-listed classical swine fever virus (CSFV,Pestivirus C<\/emph>) [[1<\/reflink>]], Bungowannah virus (BungoV,Pestivirus F<\/emph>), atypical swine pestivirus (APPV,pestivirus K<\/emph>) and Linda virus (LindaV,pestivirus L<\/emph>) were detected in pigs [[2<\/reflink>], [4<\/reflink>]]. BungoV emerged in 2003 and is responsible for reproductive disorders, stillborn and mummified piglets and sudden death in weaning age piglets [[2<\/reflink>]]. A single BungoV outbreak has been detected and contained in Australia, but the virus has yet to be eradicated [[5<\/reflink>]]. The spread of BungoV has been considered a threat to global swine health, but to date there is no evidence that BungoV has established itself in other regions of the world [[6<\/reflink>], [8<\/reflink>]]. In contrast, APPV occurs worldwide and is responsible for type A-II congenital tremor (CT) in piglets that causes moderate economic losses [[10<\/reflink>], [12<\/reflink>], [14<\/reflink>]].<\/p>\r\nLindaV was discovered as a new \"lateral jerk-inducing neurodegenerative agent\" on a piglet farm in Styria, Austria, in 2015 [[4<\/reflink>]]. Piglets infected in utero showed severe lateral tremors throughout the body, resulting in an inability to suck milk, leading to a high pre-weaning mortality [[4<\/reflink>]]. CT type A-II was confirmed during histopathological examinations of sick piglets with the presence of severe hypomyelination in the spinal cord and viral antigen in central nervous system (CNS) tissues [[4<\/reflink>]]. Experimental LindaV infections in immunocompetent piglets have been found to result in transient viremia and rapid seroconversion [[15<\/reflink>]]. However, the virus persisted in lymphoid tissues and was still detectable after 21 days. LindaV has so far been detected in the index case and at a farm 10 km away as a result of a nationwide LindaV neutralizing antibody test [[16<\/reflink>]]. This study revealed a very low seroprevalence of 0.15% (based on the number of sera tested) and 0.7% (at farm level) in Austria [[16<\/reflink>]]. A new genetically related LindaV strain (LindaV Austria2 strain) could be isolated from a serum sample in 2016 [[16<\/reflink>]]. Interestingly, no clinical signs of CT had ever been present in pigs on that farm, according to the farmer and the attending veterinarian.<\/p>\r\nIn this study, we report the isolation of a new LindaV strain (LindaV strain Austria3) causing a clinically relevant disease in a closed-loop farm in Carinthia, Austria, in 2020\/2021.<\/p>\r\n2. Materials and Methods<\/hd>\r\n<\/p>\r\n2.1. Farm Description<\/hd>\r\nA full cycle commercial farm in Carinthia, Austria, produces piglets with 60 Large White and Landrace cross sows in a continuous farrowing cycle. A Pietrain boar is used for semen production, natural insemination and sexual stimulation of sows, which are artificially inseminated. Piglets are weaned at 28 days of age. Piglets are routinely vaccinated againstMycoplasma hyopneumoniae<\/emph> and against porcine circovirus 2 (PCV2) using inactivated vaccines (M. hyopneumoniae<\/emph> in the first week of life with SuvaxynMH-One, Zoetis\u0dsterreich GmbH, Vienna, Austria; PCV2 at 21 days old with Suvaxyn Circus, Louvain-la-Neuve, Belgium).<\/p>\r\nPrior to the onset of reproductive disorders, new gilts were purchased in March 2020 from a commercial gilt producer and introduced into the herd after an eight-week isolation phase. Gilts and sows are immunized against parvovirus and erysipelas by a combined inactivated vaccine (Parvoruvac, Ceva Sant\u00e9 Animale, Libourne, France) in the isolation unit and at weaning, respectively. Sows and gilts are vaccinated against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) using a modified live virus vaccine (Porcilis PRRS, Intervet GesmbH, Vienna, Austria) at five-month intervals. Vaccination against swine influenza A virus using a trivalent vaccine was introduced after the onset of reproductive disorders.<\/p>\r\n2.2. Diagnostic samples<\/hd>\r\nSamples were obtained by veterinarians from the University Pig Clinic (Vienna University of Veterinary Medicine) for diagnostic purposes during a farm visit. Therefore, ethical approval was not required for this study. A one-day-old non-viable piglet and an eight-week-old weanling piglet with paralysis of both hind legs were humanely sacrificed under general anesthesia (anesthesia: 1.3 mg/kg azaperone and 10 mg/kg azaperone hydrochloride ). euthanasia: T61 (5.0 mg\/mL of tetracaine hydrochloride, 50 mg\/mL of mebezonium iodide and 200 mg\/mL of embutramide; 1 mL\/10 kg)). The following tissues were collected from euthanized piglets: parotid gland, tonsil, lymph node (inguinal, tracheobronchial and mesentery), heart, lung, liver, pancreas, duodenum, jejunum, ileum, cecum, colon, kidney, genital tract, urinary bladder, thymus , spleen, cerebellum, medulla oblongata, spinal ganglion, spinal cord, sciatic nerve and umbilical cord (newborn piglets only). EDTA-treated whole blood and blood samples were collected from two sows with previous CT litters, 15 piglets weaned and 2 piglets euthanized as mentioned above (blood sample only from 8-week-old euthanized weaned piglets treated with EDTA). Pooled fecal samples were collected from the gestation pen, farrowing crates and table. Semen and a saliva sample were obtained from the boar. Additional saliva swabs were collected from 12 sows and gilts and 15 weaned piglets (pooled swab sample from weaned piglets). A pooled sample of placenta from newly farrowed sows and tails from newborn piglets was also obtained.<\/p>\r\n
In addition, the veterinary diagnostic laboratory of the federal state of Carinthia kindly provided paraffin-embedded tissue samples (brain, liver, spleen, kidney, gastrointestinal tract, lung and heart) from a CT-affected piglet. These tissue samples were obtained during the acute congenital tremor phase in December 2020.<\/p>\r\n23. Pathological Examination and Immunohistochemistry<\/hd>\r\nA complete necropsy was performed on the eight-week-old weaned pig, euthanized due to paralysis of both hind legs. Samples of the brain, spinal cord, peripheral nerves, liver, spleen, kidneys, gastrointestinal tract, lung, lymph nodes, tonsils, thymus, pancreas and salivary glands were fixed in 4% buffered formalin and embedded in paraffin. Two µm-thick sections were cut and stained with hematoxylin and eosin (HE). Selected brain and spinal cord samples were stained with a combination of luxol fast blue and HE to assess myelin content. In addition, paraffin-embedded samples (brain, liver, spleen, kidney, gastrointestinal tract, lung and heart) from a piglet affected by CT, which was confirmed LindaV positive by RT-PCR, were stained with HE. /p >\r\n
CNS samples from both pigs were evaluated by immunohistochemistry using an anti-pestivirus E2 primary antibody (mouse monoclonal antibody (mAb) 6A5, 1:100 dilution) for the detection of LindaV. The stains were performed automatically in an autostainer (Lab Vision AS 360, Thermo Fisher Scientific, Waltham, MA, USA). Antigenic retrieval was performed by pronase digestion. After application of the primary antibody, a polymer detection system (UltraVision LP Large Volume Detection System; Thermo Fisher Scientific, Waltham, MA, USA) was used, which consists of a universal formulation of secondary antibody conjugated to an enzyme-labelled polymer. . The polymeric complex was then visualized with diaminobenzidine (Labvision/Thermo Fisher Scientific, Waltham, MA, USA). Sections were counterstained with hematoxylin. Formalin-fixed and paraffin-embedded spinal ganglia from pigs from the previous LindaV outbreak in 2015 served as positive and negative controls, respectively.<\/p>\r\n2.4. Isolation of peripheral blood mononuclear cells (PBMC)<\/hd>\r\nEDTA-treated blood was centrifuged for 10 min at 2000g<\/emph> and 4 \u00b0C. Plasma was collected from the supernatant and stored at -0°C. The buffy coat was carefully removed (approximate volume of 1 ml), transferred to a centrifuge tube containing 5 ml of erythrocyte lysis buffer (EL buffer, QIAGEN, Hilden, Germany) and shaken vigorously. The mixture was incubated for 10 min at 4°C, followed by a centrifugation step for 10 min at 1000°Cg<\/emph> and 4 \u00b0C. The supernatant was removed and the procedure was repeated twice. Finally, the PBMC pellet was resuspended in 1 mL of Dulbecco's modified Eagle medium (DMEM, Biowest, Nuaill\u00e9, France).<\/p>\r\n2.5. Cell culture<\/hd>\r\nSK-6 cells [[17<\/reflink>]] in DMEM (Biowest) supplemented with 10% heat-inactivated fetal calf serum (FCS, Corning, Tewksbury, MA, USA; tested negative for pestivirus), 100 U\/mL of penicillin and 100 \u00b5g\/mL of streptomycin. Cells were maintained at 37 °C and 5% CO2<\/subs>.<\/p>\r\n2.6. Indirect immunofluorescence assay<\/hd>\r\nThe indirect immunofluorescence assay was performed as previously described [[4<\/reflink>]]. Briefly, SK-6 cells were fixed with 4% paraformaldehyde in PBS for 20 min at 4°C and permeabilized with 1% Triton-X 100 (Merck, Darmstadt, Germany) in PBS for 5 min at room temperature. The cross-reactive mAb 6A5 (anti-BVDV E2) was used as the primary antibody and a Cy3-conjugated goat anti-mouse IgG (Dianova, Hamburg, Germany) was used as the secondary antibody.<\/p>\r\ n2.7. Virus Isolation<\/hd>\r\nA total volume of 50 µl of PBMC resuspended in DMEM (as described in Section 2.4) was co-cultured with 5 µl 104 <\/sups> SK-6 cells in a 24-well cell culture plate (STARLAB, Hamburg, Germany). Cells and cell culture supernatant were passaged 72 h after co-cultivation. Successful infection of SK-6 cells was detected by an indirect immunofluorescence assay (as described in Section 2.6) and a LindaV-specific RT-qPCR assay (as described in Section 2.9).<\/p> \r \n2.8. Serum virus neutralization assay (SVN)<\/hd>\r\nThe SVN assay was performed as previously described [[16<\/reflink>]]. Briefly, sera were heat-inactivated at 56°C for 30 min and a 5-fold serial dilution (1/5 initial dilution, 1/390.625 final dilution) was prepared in DMEM (Biowest) in a culture dish. 96-well cell. (STARLAB). A piece of LindaV labeled with mCherry (1.78 \u00d7 105<\/sup> TCID50<\/subs>\/mL) diluted to 100 TCID50<\/subs>\/50 \u00b5L, are added to serum dilutions and incubated for 2 h. A total number of 1 \u00d7 104 SK-6 cells were added to the serum/virus mixture and then incubated for 72h. Serum controls, cell controls, positive and negative reference antisera, and a virus back-titration were included. Cells were fixed with 4% paraformaldehyde and evaluated under a fluorescence microscope (Olympus IX70 fluorescence microscope; OLYMPUS, Hamburg, Germany).<\/p>\r\nThe 50% neutralization dose (ND50<\/subs>\/mL) was calculated based on the Spearman-Kaerber method and expressed as the reciprocal value (1\/ND50<\/subs>\/mL) of serum dilution.<\/p>\r\n2.9. LindaV-specific RNA extraction and RT-qPCR assay<\/hd>\r\nTotal RNA extraction was performed with the QIAamp Viral RNA Mini Kit (QIAGEN) according to the manufacturer's instructions. A total volume of 140 µl of serum, plasma or semen was used directly for RNA extraction. Saliva swab samples were wetted with 1 mL of PBS, mixed by vortexing, then centrifuged and 140 5L of supernatant used for RNA extraction. Each 100 mg tissue sample was mixed with 1 ml of PBS in a 2 ml microcentrifuge tube containing stainless steel beads and homogenized at a rate of 30/sec for 3 min using a TissueLyser II (QIAGEN). After centrifugation, a volume of 140 \u00b5L of supernatant from the homogenate was used for extraction. PBMCs were lysed by three freeze/thaw cycles, cell debris was removed by centrifugation, and 140 µl of supernatant was used for RNA extraction.<\/p>\r\n
For LindaV RNA detection, a LindaV-specific RT-qPCR assay was performed on a Rotor-Gene Q cycler (QIAGEN) using the Luna Universal Probe One-Step RT-qPCR kit (NEB, Ipswich, Massachusetts, USA). ) as previously described [[15<\/reflink>]]. A beta-actin RT-qPCR assay was used as an internal control as previously described [[16<\/reflink>]] under the same cycling conditions as the LindaV RT-qPCR assay. Saliva swab samples were spiked with a plasmid containing the enhanced green fluorescent protein (EGFP) coding sequence prior to RNA extraction to exclude inhibitory factors in RT-qPCR performance, since beta-actin RT-qPCR produces inconsistent results on analysis of this sample material Oligonucleotides EGFP-F (5'-GACCACTACCAGCAGAACAC-3'), EGFP-R (5'-GAACTCCAGCAGGACCATG-3'), and EGFP probe -HEX (5'-HEX- AGCACCCAGTCCGCCCTGAGCA-BHQ-1-3') for the amplification of a 132 bp fragment of the EGFP sequence, as described by Hoffmann et al. [[18<\/reflink>]], under the same cycling conditions as the LindaV RT-qPCR assay.<\/p>\r\nA ten-fold dilution series of a plasmid containing the target sequence for the LindaV RT-qPCR assay was included in each series to obtain a standard curve for quantification of viral load in samples as described previously [[15<\/reflink>]]. Briefly, the Rotor-Gene Q software (version 2.3.4.; QIAGEN) estimated the number of copies per reaction based on the number of DNA copies of the input plasmid and converted it into the respective equivalent genomes of each sample ( GE\/ mL , GE\ /g or GE\/swab). As we used a DNA standard and not an RNA standard in our RT-qPCR assay, the efficiency of the reverse transcription step could not be evaluated, which could lead to small biases in the copy number calculations.< \/p >\r\n2.10. RT-PCR, Sanger sequencing and sequence analysis<\/hd>\r\nA pan-pestivirus RT-PCR amplifying a fragment of the NS5B coding region was performed using the OneTaq One-Step RT-PCR Kit (NEB) and oligonucleotides as previously described [[4<\/reflink>]]. The following cycling conditions were used: 48°C for 20 min, 94°C for 1 min, followed by 45 cycles of 94°C for 15 s, 50°C for 30 s, 68°C for 1:10 min, and a final elongation at 68°C. \u00b0C for 5 min. The amplicon of approximately 800 bp in length was purified using Quantum Prep PCR Kleen Spin Columns (Bio-Rad, Hercules, CA, USA) and the sequence of the purified PCR product was determined by Sanger sequencing (Eurofins Genomics, Ebersberg, Germany ) . ). The obtained sequence was analyzed using the Basic Local Alignment Nucleotide Search Tool (BLASTN) (https:\/\/blast.ncbi.nlm.nih.gov\/Blast.cgi?PROGRAM=blastn&PAGE%5fTYPE=BlastSearch&LINK%5fLOC=blasthome, accessed June 4, 2021).<\/p>\r\nThe complete genome of the new LindaV Austria3 strain (GenBank accession number: OK086026) was obtained by a two-step RT-PCR approach with the generation of overlapping PCR fragments using oligonucleotides and cycling conditions as previously described [[16<\/reflink>]]. PCR products were purified using Quantum Prep PCR Kleen Spin Columns (Bio-Rad) and sequences determined by Sanger sequencing (Eurofins Genomics). For determination of the complete genomic sequence of the new LindaV strain, a consensus sequence lacking only the 5' and 3' ends was generated and compared with available LindaV sequences (GenBank accession numbers: KY436034.1 (LindaV strain Austria1) and MZ027894 .1 (Strain LindaV Austria2)). Sequence analysis was performed with DNA Strider 3.0 software [[19<\/reflink>]] and CLC Sequence Viewer 7.7.1 (CLC Bio\/QIAGEN Digital Insights, Aarhus, Denmark).2.11. Phylogenetic analysis<\/hd>\r\nPhylogenetic analysis was performed using CLC Sequence Viewer 7.7.1 (CLC bio\/QIAGEN Digital Insights, Aarhus, Denmark) based on complete genomic sequences. For the construction of the phylogenetic tree, the algorithm of union of neighbors and bootstrap with 1000 repetitions was used. The following pestivirus sequences were used for analysis: Linda Austria1 virus strain (KY436034.1,Pestivirus L<\/emph>), cepa do virus Linda Austria2 (MZ027894.1), cepa do virus Linda Austria3 (OK086026), Bungowannah virus (EF100713.2,Pestivirus F<\/emph>), Dongyang pangolin pestivirus isolate DYAJ1 (MK636874.1,Pestivirus P<\/emph>), Phocoena pestivirus isolate NS170386 (MK910229.1,Pestivirus M<\/emph>), pestivirus porcino atípico 1 cepa AUT-2016_C (KX778724.1,pestivirus K<\/emph>) and classical swine fever virus strain Alfort_187 (X87939.1,Pestivírus C<\/emph>).<\/p>\r\n3. Results<\/hd>\r\n<\/p>\r\n3.1. Description of the new essay LindaV<\/hd>\r\nIn autumn 2020, a full-cycle farm in the federal state of Carinthia in southern Austria (Figure 1) reported cases of reproductive disorders (miscarriages, neonatal deaths, stillbirths and mummified piglets) in several sows and gilts. Symptoms began in October 2020, when four sows farrowed four weeks before the estimated farrowing date. These piglets were born alive but died shortly after birth. The next seven litters showed known symptoms of parvovirus: mummies at different stages of development, stillbirths and piglets born alive. The episode of reproductive failure was followed by the appearance of severe CT in a total of 20 litters and was associated with a high pre-weaning mortality of 80-90% in December 2020 (Video S1). The last litters affected by CT occurred in early January 2021. During the CT episode on the farm, approximately 10–20% of the piglets were born weak and the rate of return to estrus was 10%. The number of piglets weaned per sow per year dropped from an average of 28 to an average of 22 due to reproductive disorders and piglet mortality. Pooled organ samples from five piglets affected by CT were sent to the University of Veterinary Medicine in Vienna in mid-January 2021. Analysis of the organ samples using pan-pestivirus RT-PCR in the NS5B region yielded a positive result. In the diagnostic laboratory of the Institute of Virology at the University of Veterinary Medicine in Vienna, PRRSV and porcine parvovirus (PPV) were excluded by PCR as differential diagnoses, and PCV2 qPCR results were below the level of quantification. Sequencing of the NS5B pestiviral amplicon of approximately 800 bp in length and analysis of the consensus sequence using the Basic Site Alignment Nucleotide Search Tool (BLASTN) revealed 98.3% sequence identity for the Austria1 strain of LindaV found in 2015 (GenBank accession number: KY436034.1). Pooled organ samples were retested using LindaV-specific RT-qPCR in the 5'-UTR region, which determined a very high viral load of 3.9' 108<\/sups>GE\/g.<\/p>\r\nSubsequently, a farm visit was carried out in February 2021 to diagnose the disease outbreak. At this time, no clinical symptoms associated with LindaV infection were observed and reproduction data approached pre-outbreak levels. Two sows, which farrowed the day before the farm visit, received homogeneous litters of clinically healthy newborn piglets. All other sows and suckling piglets in the farrowing barn appeared clinically healthy. A batch of six-week-old weanling piglets that survived the TC phase presented as a heterogeneous group with weak and weak piglets. An eight-week old breeding pig suffering from paralysis of both hind legs was observed and humanely euthanized. All sows and the neck appeared clinically healthy, while a mild dry cough was observed in finishing pigs.<\/p>\r\n3.2. Diagnostic job<\/hd>\r\n<\/p>\r\n3.2.1. Serum virus neutralization assay<\/hd>\r\nSera from 15 six-week-old weaned piglets (P1-P15), plasma from an eight-week-old weaned piglet, sera from two sows with previous CT litters, and serum from a one-day-old non-viable piglet were analyzed. parsed in the SVN test (as described in Section 2.8).<\/p>\r\n
High titers of neutralizing antibodies \u22651\/193.2 ND50<\/subs>\/ml were detected in nine weaned piglets (P1, P5, P7\u2013P9 and P12\u2013P15). Intermediate to low titers of neutralizing antibodies between 1/17.2 ND50<\/subs>\/mL e 1\/86,4 ND50<\/subs>\/mL were found in four animals (P2, P6, P10 and P11). Two newly weaned piglets (P3 and P4) did not show neutralizing activity (Figure 2). A high neutralizing activity of 1\/10,640 ND50<\/subs>\/mL was determined in the plasma of an eight week old weaned piglet sacrificed for paralysis of both hind legs. Two sows with previous CT litters showed strong neutralizing activity against LindaV (both 1/2180 ND50<\/subs>\/mL). No neutralizing activity was detected in a one day old non-viable piglet.<\/p>\r\n3.2.2. LindaV-specific RT-qPCR assay<\/hd>\r\nLindaV-specific RT-qPCR assay and RT-qPCR assays for beta-actin and eGFP internal control genes were performed as described in Section 2.9. All samples tested in the LindaV RT-qPCR assay were RT-qPCR positive for the internal control genes beta-actin and eGFP.<\/p>\r\n
LindaV-specific RT-qPCR assay results of six-week-old weaned piglets (P1-P15; serum, plasma, and PBMC) are shown in Figure 2 and described in detail in Supplementary Table S1. Analysis of a saliva swab sample and a stool sample from six-week-old weaned piglets (P1-P15) confirmed viral shedding, showing a high viral load of 1.17-106<\/sups> GE\/swab (pooled saliva swab sample) and 2.65 \u00d76<\/sups> GE\/g (combined fecal sample) (Supplementary Table S1).<\/p>\r\nFurthermore, tissue samples from different organs and blood samples (plasma and PBMC) from an eight-week-old weaned pig sacrificed due to paralysis of both hind legs were analyzed in the RT-qPCR assay. LindaV RNA was detected in lymphoid organs (inguinal lymph nodes and tonsils) and tissues of the CNS (cerebellum and medulla oblongata) and peripheral nervous system (PNS; spinal ganglion). Viral loads ranged from 2.25 \u00d7 105<\/sups> GE\/g a 5,36 \u00d7 106<\/sups> GE\/g (Supplementary Table S2). All other tissue samples were negative by RT-qPCR and viremia was not detected in this animal.<\/p>\r\nLindaV RNA was not detectable in any of the samples obtained from sows and gilts (feces, saliva swab samples and blood samples). All samples obtained from the boar, newborn piglets and the combined placental sample were negative by LindaV-specific RT-qPCR.<\/p>\r\n3.2.3. Virus Isolation<\/hd>\r\nVirus isolation was performed by co-cultivating PBMC with susceptible SK-6 cells (as described in Section 2.7). Virus isolation was successful in 7 out of 15 weaned piglets (P1-P4, P6, P10 and P11) (Figure 2 and Supplementary Table S1). No virus could be isolated from the PBMC of the sows and the day-old euthanized piglet.<\/p>\r\n3.2.4. Histopathology and Immunohistochemistry<\/hd>\r\nParaffin-embedded samples from the cerebellum and brainstem of a CT piglet were available for histological and immunohistochemical evaluation (as described in Section 2.3). HE staining showed no lesions, but LindaV could be detected in the cytoplasm of neurons by immunohistochemistry (Figure 3).<\/p>\r\n
In addition, tissue samples from the eight-week-old weaned piglet were analyzed. Immunohistochemistry for LindaV detection did not show a positive result in any of the tissues. In determining the cause of the paralysis of both hindlimbs, randomly distributed foci of neuronal necrosis were detected in the gray matter and white matter degeneration of the caudal cervical spinal cord with very mild reactive changes and scattered small hemorrhages. The etiology of these lesions could not be revealed. There were scattered multifocal perivascular lymphoplasmacellular infiltrates in the brain and spinal cord.<\/p>\r\n3.3. Genetic characterization of the new strain LindaV Austria3<\/hd>\r\nThe complete genome sequence of the new strain LindaV Austria3 (OK086026) was obtained using a two-step RT-PCR approach and Sanger sequencing. We chose the sample with the highest viral load in the RT-qPCR assay (3.16 \u00d7 108<\/sups> GE\/mL; PBMC from the P3 weanling pig) for this sequencing attempt. A consensus sequence of 12,568 nt was determined and compared to sequences from the LindaV Austria1 strain (KY436034.1) and the LindaV Austria2 strain (MZ027894.1) (Figure 4). Interestingly, the LindaV Austria2 strain and the LindaV Austria3 strain were found to be slightly more closely related than the index case, the LindaV Austria1 strain; overall nucleic acid sequence identity was 98.9% compared to 98.5%, respectively. Sequence identities between the different coding regions of the LindaV genome are shown in Figure 4B. The divergence in nucleic acid sequence resulted in a comparable overall amino acid identity of 98.3% between LindaV Austria1 strain and LindaV Austria2 strain, as well as LindaV Austria1 strain and LindaV Austria3 strain. In contrast, the total amino acid identity was 99.1% when comparing the LindaV Austria2 strain to the LindaV Austria3 strain.<\/p>\r\n4. Discussion</\/hd>\r\nThe discovery of LindaV in Styria, Austria, in 2015 expanded the group of pestiviruses that infect swine host species and revealed the much-sought-after European relative of BungoV from Australia [[4<\/reflink>]]. Despite a high level of attention following the first LindaV outbreak, no signs of viral spread or the existence of this virus in other herds were observed [[8<\/reflink>], [12<\/reflink>]]. However, LindaV was found on a farm 10 km from the index case by retrospective serosurveillance without clinical indications [[16<\/reflink>]]. In this article, we describe a new outbreak of LindaV that occurred six years later in another province of Austria. As in the index case, CT and high pre-weaning mortality in piglets occurred after reproductive disorders in sows. Furthermore, LindaV was detectable in six-week-old pigs that underwent CT as newborn piglets, suggesting a chronic or persistent infection in these animals.<\/p>\r\nIntrauterine infections with pestivirus in early pregnancy may cause immune tolerance [[21<\/reflink>], [23<\/reflink>], [25<\/reflink>]]. Immunotolerant animals become persistently infected (PI) and shed large amounts of virus throughout their lives. After intrauterine infection of the fetus with BungoV, a prolonged high-level viremia above 106<\/sups> GE\/mL were observed up to 75 days of age [[25<\/reflink>]]. Although there is still a lack of studies evaluating the outcome of fetal infection with LindaV, high-level viremia of up to 3 \u00d7 108 <\/sups> GE\/mL together with the lack of humoral immune response against LindaV in individual animals (P3 and P4 piglets) indicate the occurrence of such chronically, possibly persistently infected animals. In addition, these six-week-old animals shed large amounts of virus via the fecal and oral routes, which supports this hypothesis.<\/p>\r\nHigh titers of neutralizing antibodies were found in some viremic piglets, which may have been acquired passively by ingestion of colostrum. Unfortunately, in our test it was not possible to discriminate between maternally derived and actively acquired antibodies. Maternally derived antibody titers can last a long time after pestivirus infection. Maternal antibodies against BVDV were detected around 190 days [[26<\/reflink>]] and against VPSC for a period of seven weeks [[27<\/reflink>]]. Therefore, the presence of maternal antibodies cannot be excluded.<\/p>\r\nPBMC have been shown to represent a reliable sample for detecting BVDV cell-associated viremia [[28<\/reflink>]] e CSFV [[29<\/reflink>]]. In this study, we detected high LindaV RNA viral loads in PBMC and isolated the virus by co-cultivation with SK-6 cells. Several highly viremic animals showed a 10-fold higher viral load in PBMCs compared to serum and plasma, suggesting that the PBMC assay represents a more sensitive detection method for the viremic phase of LindaV infections. PBMC virus isolation was successful from 2.58 \u00d7 105<\/sups> GE\/mL, although a high neutralizing antibody titer of 1\/434 ND50<\/subs>\/mL were observed in one animal (P1). In this case, attempts to isolate the virus from serum or plasma may lead to false negative results due to circulating neutralizing antibodies.<\/p>\r\nIn the eight-week-old weanling pig suffering from paralysis of both hind legs, acute focally extensive gray and white matter lesions were present in the caudal cervical spinal cord with only a mild reaction. Neither the distribution nor the type of lesions was representative of a viral infection. Therefore, it was thought that the lesions were probably of ischemic or traumatic origin. Unrelated to these lesions, scattered multifocal perivascular lymphoplasmacellular infiltrates were detected in the brain and spinal cord, which may be due to LindaV infection, consistent with viral RNA detected in CNS structures by RT-qPCR. Negative results in immunohistochemical analysis may indicate a lower sensitivity of this technique compared to the RT-qPCR assay.<\/p>\r\n
There is a high sequence identity between the three currently known LindaV strains (Austria1–Austria3). We found no evidence of transmission or epidemiological links between the cases in Styria and the new outbreak in Carinthia. Therefore, we must assume a low but constant prevalence of LindaV in southern Austria. The purchase of new gilts from a commercial gilt producer and the outbreak of the disease approximately six months after introduction into the pig herd could be a possible route of transmission. Investigations into the presence of LindaV at the gold production facility are ongoing. However, gilt farms in Austria often sell pigs to multiple pig farms and a single disease outbreak would be unlikely given the low seroprevalence of LindaV infections in the Austrian pig population [[16<\/reflink>]]. As our seroprevalence study was unable to detect reservoirs in domestic swine herds, it is reasonable to postulate a reservoir host in nature. Wild boar and ruminant species may represent the LindaV reservoir. Because pestiviruses have also been described in the recent past in some non-biungulate animals [[30<\/reflink>], [32<\/reflink>]], other wildlife reservoirs such as rodents or bats cannot be excluded. To prevent further introduction of the virus into the domestic swine population, identification of reservoir hosts is essential. Constant vigilance should also be established in the at-risk region of southern Austria to prevent spread through clinically inconspicuous long-term viremic animals.<\/p>\r\n5. Patents<\/hd>\r\nThe authors B.L., L.S. and T. R. are the inventors of a patent on the LindaV pestivirus (PCT\/EP2017\/084453; Isolation of a new pestivirus that causes congenital tremor).<\/p>\r\nCifras<\/hd>\r\nGraph: Figure 1 Location of farms where Linda virus strains Austria1, Austria2 and the new Austria3 (LindaV) were isolated. The stars indicate the location of the farms. Different shades of brown mark regions with high (dark brown) and low (light brown) density of pigs. Linda V: Linda virus. (Modified from: (Accessed 18 Aug 2021). \u00a9 Statistics Austria\u2014Cartography and GIS, Created 1 Sep 2018.)<\/p>\r\n
Graph: Figure 2 Results of serum virus neutralization (SVN) assay (ND50/mL), LindaV-specific RT-qPCR assay of serum, plasma, and PBMC (GE/mL), and viral isolation from six um PBMCs week-old weaned piglets (P1-P15). Viral particles represent successful viral isolation via co-cultivation of PBMCs with SK-6 cells. Neutralizing antibody titers are given as the reciprocal ND50 value and error bars indicate positive and negative standard deviations. ND50, 50% neutralization dose; GE, genome equivalents; PBMC, peripheral blood mononuclear cell.<\/p>\r\n
Graph: Figure 3 Detection of LindaV by immunohistochemistry in the cytoplasm of neurons (arrowheads) in the brainstem of a CT piglet. Primary antibody: monoclonal antibody 6A5 specific for pestivirus E2; contrast: hematoxylin, magnification 400\u00d7, insertion 600\u00d7.<\/p>\r\n
Graph: Figure 4 Phylogenetic analysis of selected pestivirus species and sequence analysis of complete genomic sequences of Linda virus strains known to date. (A) A rootless phylogenetic tree was constructed based on the complete genomic sequences of LindaV strain Austria1, LindaV strain Austria2, LindaV strain Austria3, Bungowannah virus, Phocoena pestivirus isolate NS170386, Dongyang pangolin pestivirus isolate DYAJ, CSFV strain Alfort_187, and APPV strain AUT -2016_C using neighbor join algorithm and starting with 1000 replicas. Bootstrap values are displayed in percentage on each node. (B) Sequence identities between the different coding regions of the viral genome of LindaV Austria1, Austria2 and Austria3 strains are given in percentage. Non-structural protein coding regions are highlighted in dark green and structural protein coding regions are highlighted in light green. DYPV, Dongyang pangolin pestivirus; PhoPeV, Phocoena pestivirus; BungoV, Bungowannah virus; APPV, porcine atypical pestivirus; CSFV, classical swine fever virus; UTR, untranslated region; C, Nucleus; E, envelope glycoprotein; NS, non-structural protein.<\/p>\r\nAuthor Contributions<\/hd>\r\nConceptualization, L.S., C.R., B.L. and T.R.; methodology, A.K., C.R., S.H., R.B., B.L. and T.R.; validation, A.K., L.S., B.L. and T.R.; formal analysis, A.K., L.S., A.L. and B.L.; research, A.K., L.S., C.R., S.H., R.B., K.D., A.A., M.Z., M.M. and K.S.; Resources, A.L., B.L. and T.R.; data curation, A.K. and LS; writing — preparing the original draft, A.K., L.S., S.H. and T.R.; writing - proofreading and editing, all authors; display, A.K. and S.H.; supervision, L.S., C.R., A.L., B.L. and T.R.; project management, T.R.; acquisition of funds, T.R. All authors have read and accepted the published version of the manuscript.<\/p>\r\nFinancing<\/hd>\r\nThis research was funded by Boehringer Ingelheim Vetmedica GmbH (Binger Strasse 173, 55216 Ingelheim am Rhein, Germany, contract number: 396806).<\/p>\r\nInstitutional Review Board Statement<\/hd>\r\nEthical review and approval was waived for this study as samples were collected by licensed veterinarians as part of a farm visit for diagnostic purposes.<\/p>\r\nDeclaration of informed consent<\/hd>\r\nNot applicable.<\/p>\r\nDeclaration of Data Availability<\/hd>\r\nAll data analyzed or generated during this study are included in the manuscript.<\/p>\r\nConflicts of interest<\/hd>\r\nThe authors declare no conflict of interest. Funders had no role in study design; in the collection, analysis or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.<\/p>\r\nThanks<\/hd>\r\nWe thank the breeders and the veterinarian in charge of the herd for their cooperation and Kati Szakmary-Br\u00e4ndle, Hann-Wei Chen and Petra Kodajova for their excellent technical assistance. Open access funding from the Vienna University of Veterinary Medicine.<\/p>\r\nSupplementary Materials<\/hd>\r\nThe following support information can be downloaded from: https:\/\/www.mdpi.com\/article\/10.3390\/v14020326\/s1,<\/ulink> Video S1: Piglets affected with congenital tremor (CT), Supplementary table S1: Results of serum virus neutralization assay (SVN) (1 / NORTH DAKOTA50<\/subs>\/mL), RT-qPCR assay (GE\/mL; GE\/g; GE\/swab) and virus isolation from six-week-old weaned piglets, Supplementary Table S2: Results of SVN attempt (1\/ND50<\/subs>\/mL), RT-qPCR assay (GE\/mL, GE\/g) and virus isolation from an eight-week-old weaned piglet with paralysis of both hind legs.< \ / p>\r\n[\r\nFootnotes <\/title>\r\n\r\n1<\/biblia>\r\nEditor's Note: MDPI remains neutral regarding jurisdictional claims on published maps and institutional affiliations.<\/bibtext>\r\n <\/blist>\r\n <\/ref>\r\n][\r\nReferences <\/title>\r\n\r\nOIE Terrestrial Animal Health Code Available online: https:\/\/www.oie.int\/en\/what-we-do\/standards\/codes-and-manuals\/terrestrial-code-online-access\/(acessado<\/ulink> em 9 de outubro de 2021)< \ /bibtext>\r\n <\/blist>\r\n\r\n2<\/biblia>\r\nKirkland P.D., Frost M.J., Finlaison D.S., King K.R., Ridpath J.F., Gu X. Identification of a new virus in pigs-bungowannah virus: a possible new species of pestivirus. Virus Resolution 2007; 129:26-34. 10.1016\/j.virusres.2007.05.002<\/bibtext>\r\n <\/blist>\r\n\r\n3<\/biblia>\r\nHause B.M., Collin E.A., Peddireddi L., Yuan F., Chen Z., Hesse R.A., Gauger P.C., Clement T., Fang Y., Anderson G. Discovery of a novel putative type of swine pestivirus in non-US pigs. J. Gen. Virol. 2015; 96: 2994–2 10.1099\/jgv.0.000251<\/bibtext>\r\n <\/blist>\r\n\r\n4<\/biblia>\r\nLamp B., Schwarz L., H\u00f6gler S., Riedel C., Sinn L., Rebel-Bauder B., Weissenb\u00f6ck H., Ladinig A., R\u00fcmenapf T. New pestivirus species in porcos, Austria, 2015. Emerg. Infect. Dis. 2017; 23: 1176-1179. 10.3201\/eid2307.170163<\/bibtext>\r\n <\/blist>\r\n\r\n5<\/biblia>\r\nKirkland P.D., Read A.J., Frost M.J., Finlaison D.S. Bungowannah virus\u2014A probable new species of pestivirus\u2014What have we found in the last 10 years?. Animation Health Res. Rev. 2015; 4:60-63. 10.1017\/S1466252315000031<\/bibtext>\r\n <\/blist>\r\n\r\n6<\/biblia>\r\nMichelitsch A., Dalmann A., Wernike K., Reimann I., Beer M. Seroprevalences of newly discovered porcine pestiviruses in German pig farms. Veterinarian. science 2019; 686. 10.3390\/vetsci6040086. 31717716<\/bibtext>\r\n <\/blist>\r\n\r\n7<\/biblia>\r\nAbrahante J.E., Zhang J.W., Rossow K., Zimmerman J.J., Murtaugh M.P. Surveillance of bungowannah pestivirus in the US cross-border Upper Midwest. Dis. 2014; 61:375-377. 10.1111\/tbed.12035<\/bibtext>\r\n <\/blist>\r\n\r\n8<\/biblia>\r\nCagatay G.N., Antos A., Meyer D., Maistrelli C., Keuling O., Becher P., Postel A. Frequent infection of boars with atypical porcine pestivirus (APPV). Cross-border. dis emerging 2018; 65: 1087–1093. 10.1111\/tbed.12854. 29527814<\/bibtext>\r\n <\/blist>\r\n\r\n9<\/biblia>\r\nM\u00f3sena AC S., Weber M.N., Cibulski S.P., Silva M.S., Paim W.P., Silva G.S., Medeiros A.A., Viana N.A., Baumbach L.F., Puhl D.E. Survival of pestivirus in transspace pigs in southern Brazil. J. Vet. Diagnosis investigating 2020; 32: 136-141. 10.1177\/1040638719896303. 31924139<\/bibtext>\r\n <\/blist>\r\n\r\nYuan J., Han Z., Li J., Huang Y., Yang J., Ding H., Zhang J., Zhu M., Zhang Y., Liao J. Atypical porcine pestivirus as a new type of pestivirus in pigs na China. Head. Microbiol. 2017; 8: 862. 10.3389\/fmicb.2017.00862. 28553280<\/bibtext>\r\n <\/blist>\r\n\r\nBeer M., Wernike K., Dr\u00e4ger C., H\u00e4per D., Pohlmann A., Bergermann C., Schr\u00fder C., Klinkhammer S., Blome S., Hoffmann B. High prevalence of highly variable Atypical swine pestivirus found in Germany. Cross border. Dis. 2017; 64: e22-e26. 10.1111\/tbed.12532<\/bibtext>\r\n <\/blist>\r\n\r\nKaufmann C., Stalder H., Sidler X., Renzullo S., Gurtner C., Grahofer A., Schweizer M. Long-term circulation of atypical swine pestivirus (APPV) in Switzerland. virus 2019; 11653. 10.3390\/v11070653<\/bibtext>\r\n <\/blist>\r\n\r\nPostel A., Meyer D., Cagatay G.N., Feliziani F., De Mia G.M., Fischer N., Grundhoff A., Mili\u0107evi\u0107 V., Deng M.C., Chang C.Y. High abundance and genetic variability of atypical porcine pestiviruses in pigs from Europe and Asia. Infect popup. Dis. 2017; 23: 2104-2107. 10.3201\/eid2312.170951. 29148382<\/bibtext>\r\n <\/blist>\r\n\r\nSchwarz L., Riedel C., H\u00f6gler S., Sinn L.J., Voglmayr T., W\u00f6chtl B., Dinhopl N., Rebel-Bauder B., Weissenb\u00f6ck H., Ladinig A. Congenital infection with infection Atypical porcine pestivirus (APPV) is associated with disease and viral persistence. Veterinarian. Resolution 2017; 48:1-14. 10.1186\/s13567-016-0406-1. 28057061<\/bibtext>\r\n <\/blist>\r\n\r\nKiesler A., Seitz K., Schwarz L., Buczolich K., Petznek H., Sassu E., D\u00fcrlinger S., H\u00f6gler S., Klang A., Riedel C. Clinical evaluation and LINDA virus serology Infections in post-weaning piglets. virus 2019; 11975. 10.3390\/v11110975. 31652833<\/bibtext>\r\n <\/blist>\r\n\r\nKiesler A., Plankensteiner J., Schwarz L., Riedel C., Seitz K., M\u00f6tz M., Ladinig A., Lamp B., R\u00fcmenapf T. Prevalence of Linda virus neutralizing antibodies in the Austrian swine population. 2021 virus; 131001. 10.3390\/v13061001<\/bibtext>\r\n <\/blist>\r\n\r\nKasza L., Shadduck J.A., Christofinis G.J. Establishment, viral susceptibility and biological characteristics of a porcine kidney cell line SK-6. Res. Veterinary. science 1972; 13:46-51. 10.1016\/S0034-5288(18)34087-6<\/bibtext>\r\n <\/blist>\r\n\r\nHoffmann B., Depner K., Schirrmeier H., Beer M. A universal heterologous internal control system for real-time duplex RT-PCR assays used in a pestivirus detection system. J. Virol. methods. 2006; 136:200-209. 10.1016\/j.jviromet.2006.05.020<\/bibtext>\r\n <\/blist>\r\n\r\nDouglas SE DNA strider. wart. Biotechnology. nine hundred ninety-five; 3:37-45. 10.1007\/BF02821333<\/bibtext>\r\n <\/blist>\r\n\r\nMarck C. \"DNA strider\": A \"C\" program for rapid DNA and protein sequence analysis on the Apple Macintosh family of computers. Nucleic Acids Res. 1988; 16: 1829-1836. 10.1093\/nar\/16.5.1829<\/bibtext>\r\n <\/blist>\r\n\r\nMcClurkin A.W., Littledike E.T., Cutlip R.C., Frank G.H., Coria M.F., Bolin S.R. Production of cattle immunotolerant to bovine viral diarrhea virus. He can. J.Comp. Medicine. 1984; 48: 156-161<\/bibtext>\r\n <\/blist>\r\n\r\nMeyer H., Liess B., Frey H.-R., Hermanns W., Trautwein G. Experimental transplacental transmission of swine cholera virus in pigs. 4. Virological and serological studies in newborn piglets. zentralbl. Veterinarian. B. 1981; 28: 659-668. 10.1111\/j.1439-0450.1981.tb01788.x<\/bibtext>\r\n <\/blist>\r\n\r\nHermanns W., Trautwein G., Meyer H., Liess B. Experimental transplacental transmission of swine cholera virus in pigs. V. Immunopathological findings in newborn pigs. zentralbl. Veterinarian. B. 1981; 28: 669-683. 10.1111\/j.1439-0450.1981.tb01789.x<\/bibtext>\r\n <\/blist>\r\n\r\nNettleton PF, Gilmour J.S., Herring J.A., Sinclair J.A. Production and survival of lambs persistently infected with border disease virus. immune compensation. Microbiol. Infect. Dis. 1992; 15: 179-188. 10.1016\/0147-9571(92)90091-5<\/bibtext>\r\n <\/blist>\r\n\r\nFinlaison DS, Kirkland PD The outcome of fetal swine infection with Bungowannah virus depends on the stage of pregnancy at which the infection occurs. Part 1: Serology and virology. virus 2020; 12691. 10.3390\/v12060691. 32604932<\/bibtext>\r\n <\/blist>\r\n\r\nFulton RW, Briggs RE, Payton ME, Confer AW, Saliki JT, Ridpath JF, Burge LJ, Duff GC. Mother-derived humoral immunity against bovine viral diarrhea virus (BVDV) 1a, BVDV1b, BVDV2, bovine herpesvirus-1, parainfluenza virus-3, bovine respiratory syncytial virus, mannheimia haemolytica, and pasteurella multocida in beef calves, decreased antibodies. Vaccines. 2004; 22: 643-6 10.1016\/j.vaccine.2003.08.033<\/bibtext>\r\n <\/blist>\r\n\r\nVandeputte J., Too H.L., Ng F.K., Chen C., Chai K.K., Liao G.A. Adsorption of colostral antibodies against classical swine fever, persistence of maternal antibodies and effect on response to vaccination in piglets. I am. J. Vet. Resolution 2001; 62: 1805-1811. 10.2460\/ajvr.2001.62.1805<\/bibtext>\r\n <\/blist>\r\n\r\nBielefeldt-Ohmann H., Ronsholt L., Bloch I. Demonstration of bovine viral diarrhea virus in peripheral blood mononuclear cells from clinically normal and persistently infected cattle. J. Gen. Virol. 1987; 68: 1971-1982. 10.1099\/0022-1317-68-7-1971<\/bibtext>\r\n <\/blist>\r\n\r\nSummerfield A., Hofmann MA, McCullough K.C. Low-density granulocytic blood cells induced during classical swine fever are targets for viral infection. Veterinarian. immune immunopathol. 1998; 63:289-301. 10.1016\/S0165-2427(98)00108-1<\/bibtext>\r\n <\/blist>\r\n\r\nWu Z., Ren X., Yang L., Hu Y., Yang J., He G., Zhang J., Dong J., Sun L., Du J. Virome assay for the identification of novel mammalian viruses in bat species from Chinese provinces. J. Virol. 2012; 86: 10999-11012. 10.1128\/JVI.01394-12. 22855479<\/bibtext>\r\n <\/blist>\r\n\r\nFirth C., Bhat M., Firth MA., Williams SH., Frye M.J., Simmonds P., Conte J.M., Ng J., Garcia J., Bhuva N.P. Detection of zoonotic pathogens and characterization of novel viruses carried by commensal rattus norvegicus in New York City. MBío. 2014; 5: e01933-14. 10.1128\/mBio.01933-1 25316698<\/bibtext>\r\n <\/blist>\r\n\r\nGao W.-H., Lin X.-D., Chen Y.-M., Xie C.-G., Tan Z.-Z., Zhou J.-J., Chen S., Holmes E.C., Zhang E Z. Newly identified viral genomes in pangolins with fatal disease. Virus evolution. 2020; 6: vera020. 10.1093\/ve\/veaa020. 32296543<\/bibtext>\r\n <\/blist>\r\n\r\nJo W.K., van Elk C., van de Bildt M., van Run P., Petry M., Jesse S.T., Jung K., Ludlow M., Kuiken T., Osterhaus A. An evolutionary divergent pestivirus that systematically lacks the gene Npro infects a species of whale. Emerging microbes infect. 2019; 8:1383-1392. 10.1080\/22221751.2019.1664940. 31526243<\/bibtext>\r\n <\/blist>\r\n <\/ref>\r\n]